Windlas Biotech consolidated net profit rises 3.18% in the December 2024 quarter
Sales rise 20.23% to Rs 195.02 crore
Net profit of Windlas Biotech rose 3.18% to Rs 15.58 crore in the quarter ended December 2024 as against Rs 15.10 crore during the previous quarter ended December 2023. Sales rose 20.23% to Rs 195.02 crore in the quarter ended December 2024 as against Rs 162.21 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales195.02162.21 20 OPM %12.6312.54 -PBDT27.2823.20 18 PBT20.3419.81 3 NP15.5815.10 3Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content